BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23289370)

  • 1. Anticoagulant therapy in patients with non-cirrhotic portal vein thrombosis: effect on new thrombotic events and gastrointestinal bleeding.
    Spaander MC; Hoekstra J; Hansen BE; Van Buuren HR; Leebeek FW; Janssen HL
    J Thromb Haemost; 2013 Mar; 11(3):452-9. PubMed ID: 23289370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy.
    Condat B; Pessione F; Hillaire S; Denninger MH; Guillin MC; Poliquin M; Hadengue A; Erlinger S; Valla D
    Gastroenterology; 2001 Feb; 120(2):490-7. PubMed ID: 11159889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
    Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study.
    Riva N; Ageno W; Poli D; Testa S; Rupoli S; Santoro R; Lerede T; Piana A; Carpenedo M; Nicolini A; Ferrini PM; Tosetto A; ;
    J Thromb Haemost; 2015 Jun; 13(6):1019-27. PubMed ID: 25845412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms.
    Hoekstra J; Bresser EL; Smalberg JH; Spaander MC; Leebeek FW; Janssen HL
    J Thromb Haemost; 2011 Nov; 9(11):2208-14. PubMed ID: 22040061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
    Artaza T; Lopes M; Romero M; Gómez AZ; de la Cruz G; Sánchez JJ; González C; Gómez R
    Gastroenterol Hepatol; 2018 Dec; 41(10):611-617. PubMed ID: 30049580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
    Loffredo L; Pastori D; Farcomeni A; Violi F
    Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
    Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
    Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study.
    Qi X; He C; Guo W; Yin Z; Wang J; Wang Z; Niu J; Bai M; Yang Z; Fan D; Han G
    Liver Int; 2016 May; 36(5):667-76. PubMed ID: 26235541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors.
    Ollivier-Hourmand I; Lebedel L; Alabau BB; Goria O; Bureau C; Dumortier J; Heurgué A; Silvain C; De-Ledinghen V; Rautou PE; Payancé A; Ballester TG; Alvarado-Tapias E; Hernández-Gea V; Valla D; Zekrini K; Nga Nguyen TT; Dao T; Garcia Pagan JC; Morello R; Plessier A
    J Hepatol; 2024 Apr; ():. PubMed ID: 38679069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis.
    Zhang Z; Zhao Y; Han B; Zhu Z; Sun L; Cui X
    Clin Appl Thromb Hemost; 2022; 28():10760296221104797. PubMed ID: 35656719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
    Sengupta N; Feuerstein JD; Patwardhan VR; Tapper EB; Ketwaroo GA; Thaker AM; Leffler DA
    Am J Gastroenterol; 2015 Feb; 110(2):328-35. PubMed ID: 25512338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
    Zhou H; Wu M; Yu S; Xia H; Yu W; Huang K; Chen Y
    BMC Gastroenterol; 2023 Sep; 23(1):329. PubMed ID: 37749527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
    Naymagon L; Tremblay D; Zubizarreta N; Moshier E; Mascarenhas J; Schiano T
    Dig Dis Sci; 2021 Oct; 66(10):3619-3629. PubMed ID: 33151401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal venous thrombosis after distal pancreatectomy: clinical outcomes.
    Kamath AS; Sarr MG; Nagorney DM; McBane RD; Farnell MB; Lombardo KM; Que FG; Donohue JH; Kendrick ML
    J Gastrointest Surg; 2014 Apr; 18(4):656-61. PubMed ID: 24553875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation Therapy for Portal Vein Thrombosis in Patients with Cirrhosis in a Tertiary Center Experience.
    Florescu MM; Costache A; Iacob SM; Pietrareanu C; Ester C; Cerban R; Dumitru R; Grasu M; Lupescu I; Gheorghe L
    J Gastrointestin Liver Dis; 2021 Sep; 30(3):374-379. PubMed ID: 34551038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.